Additive Orthopaedics received FDA 510(k) clearance for its Patient Specific 3D Printed Bone Segments for internal bone fixation in the ankle and foot.
Here are three things to know.
1. According to Additive Orthopaedics' vice president of engineering and operations Brian McLaughlin, the lattice structures have shown close to 90 percent bony in-growth after six months using no biologics.
2. Since its commercial launch in 2017, there have been more than 1,000 implantations of Additive Orthopaedics' devices.
3. The company recently closed a series B funding round of $1 million.
More articles on surface technology:
4 things to know about the U.S. launch of K2M's Mojave PL 3D Expandable Interbody System
3 things to know about Tiger Shark, ChoiceSpine's new porous titanium interbody device
'Nanotechnology is the way of the future': Dr. David DeWitt on spinal implant nanosurface technology